Optimising radiotherapy for soft tissue sarcomas: Bridging clinical evidence and technological progress
,
Germany;
Enrico Pozzo,
Italy
Soft tissue sarcomas are one of the most challenging topics in radiation oncology from both a technical and oncological standpoint, due to their histological heterogeneity, complex anatomy, and limited prospective evidence. This session explores the clinical and technological frontiers of sarcoma radiotherapy in different settings: from the current standard of care and emerging trial data for retroperitoneal sarcomas, to definitive high-dose strategies (including IMRT, hypofractionation, spatially fractionated techniques, and particle therapy) for unresectable disease; SBRT in the oligometastatic setting; and the evolving role of daily adaptive radiotherapy in optimising target coverage and sparing organs at risk
Symposium
Clinical